Corcept Therapeutics Incorporated (NASDAQ: CORT) Stock Competitors & Peer Comparison
See CORT's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CORT and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CORT | $110.77 | +2.61% | 12B | 316.49 | $0.35 | N/A |
| RPRX | $56.77 | -0.86% | 25.2B | 10.81 | $5.25 | +1.60% |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $90.22 | +0.89% | 8B | 644.43 | $0.14 | N/A |
| KNSA | $76.06 | -0.59% | 5.8B | 84.51 | $0.90 | N/A |
| TRLV | $8.75 | -2.78% | 1.5B | -20.83 | -$0.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| CUVL | $6.68 | -0.65% | 336.6M | N/A | N/A | N/A |
| LFMD | $3.56 | +4.71% | 172.2M | -7.12 | -$0.50 | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
CORT vs RPRX Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, RPRX has a market cap of 25.2B. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while RPRX trades at $56.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas RPRX's P/E ratio is 10.81. In terms of profitability, CORT's ROE is +0.08%, compared to RPRX's ROE of +0.11%. Regarding short-term risk, CORT is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for CORT.Check RPRX's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
CORT vs WBA Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas WBA's P/E ratio is -1.64. In terms of profitability, CORT's ROE is +0.08%, compared to WBA's ROE of -0.42%. Regarding short-term risk, CORT is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for CORT.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
CORT vs LQDA Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, LQDA has a market cap of 8B. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while LQDA trades at $90.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas LQDA's P/E ratio is 644.43. In terms of profitability, CORT's ROE is +0.08%, compared to LQDA's ROE of +0.47%. Regarding short-term risk, CORT is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for CORT.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
CORT vs KNSA Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, KNSA has a market cap of 5.8B. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while KNSA trades at $76.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas KNSA's P/E ratio is 84.51. In terms of profitability, CORT's ROE is +0.08%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, CORT is less volatile compared to KNSA. This indicates lower risk in terms of short-term price fluctuations for CORT.Check KNSA's competition here
Trulieve Cannabis Corp. (NYSE: TRLV)
CORT vs TRLV Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, TRLV has a market cap of 1.5B. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while TRLV trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas TRLV's P/E ratio is -20.83. In terms of profitability, CORT's ROE is +0.08%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, CORT is less volatile compared to TRLV. This indicates lower risk in terms of short-term price fluctuations for CORT.Check TRLV's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
CORT vs HROWL Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas HROWL's P/E ratio is N/A. In terms of profitability, CORT's ROE is +0.08%, compared to HROWL's ROE of -0.34%. Regarding short-term risk, CORT is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for CORT.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
CORT vs HROWM Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas HROWM's P/E ratio is N/A. In terms of profitability, CORT's ROE is +0.08%, compared to HROWM's ROE of -0.34%. Regarding short-term risk, CORT is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for CORT.Check HROWM's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
CORT vs CUVL Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, CUVL has a market cap of 336.6M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while CUVL trades at $6.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas CUVL's P/E ratio is N/A. In terms of profitability, CORT's ROE is +0.08%, compared to CUVL's ROE of N/A. Regarding short-term risk, CORT is less volatile compared to CUVL. This indicates lower risk in terms of short-term price fluctuations for CORT.Check CUVL's competition here
LifeMD, Inc. (NASDAQ: LFMD)
CORT vs LFMD Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, LFMD has a market cap of 172.2M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while LFMD trades at $3.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas LFMD's P/E ratio is -7.12. In terms of profitability, CORT's ROE is +0.08%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, CORT is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for CORT.Check LFMD's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
CORT vs LFMDP Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, LFMDP has a market cap of 160M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while LFMDP trades at $23.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas LFMDP's P/E ratio is -722.96. In terms of profitability, CORT's ROE is +0.08%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, CORT is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for CORT.Check LFMDP's competition here
Circle8 Group, Inc. (NASDAQ: CIRC)
CORT vs CIRC Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, CIRC has a market cap of 65.1M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while CIRC trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas CIRC's P/E ratio is -1.64. In terms of profitability, CORT's ROE is +0.08%, compared to CIRC's ROE of +0.00%. Regarding short-term risk, CORT is less volatile compared to CIRC. This indicates lower risk in terms of short-term price fluctuations for CORT.Check CIRC's competition here
Rite Aid Corporation (NYSE: RAD)
CORT vs RAD Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas RAD's P/E ratio is -0.05. In terms of profitability, CORT's ROE is +0.08%, compared to RAD's ROE of +2.76%. Regarding short-term risk, CORT is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for CORT.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
CORT vs GLTO Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas GLTO's P/E ratio is -1.78. In terms of profitability, CORT's ROE is +0.08%, compared to GLTO's ROE of -1.22%. Regarding short-term risk, CORT is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for CORT.Check GLTO's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
CORT vs SCYX Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, SCYX has a market cap of 33M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while SCYX trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas SCYX's P/E ratio is -1.53. In terms of profitability, CORT's ROE is +0.08%, compared to SCYX's ROE of -0.57%. Regarding short-term risk, CORT is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for CORT.Check SCYX's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
CORT vs NSRX Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, NSRX has a market cap of 29.8M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while NSRX trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas NSRX's P/E ratio is -4.80. In terms of profitability, CORT's ROE is +0.08%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, CORT is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for CORT.Check NSRX's competition here
Stablecoin Development Corp. (AMEX: SDEV)
CORT vs SDEV Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, SDEV has a market cap of 28.2M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while SDEV trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas SDEV's P/E ratio is -0.18. In terms of profitability, CORT's ROE is +0.08%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, CORT is less volatile compared to SDEV. This indicates lower risk in terms of short-term price fluctuations for CORT.Check SDEV's competition here
Biofrontera Inc. (NASDAQ: BFRI)
CORT vs BFRI Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, BFRI has a market cap of 16.3M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while BFRI trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas BFRI's P/E ratio is -1.19. In terms of profitability, CORT's ROE is +0.08%, compared to BFRI's ROE of -4.77%. Regarding short-term risk, CORT is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for CORT.Check BFRI's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
CORT vs CJJD Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas CJJD's P/E ratio is -0.46. In terms of profitability, CORT's ROE is +0.08%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, CORT is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for CORT.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
CORT vs SSY Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas SSY's P/E ratio is -2.86. In terms of profitability, CORT's ROE is +0.08%, compared to SSY's ROE of -0.09%. Regarding short-term risk, CORT is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for CORT.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
CORT vs POM Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, POM has a market cap of 5.9M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while POM trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas POM's P/E ratio is -0.17. In terms of profitability, CORT's ROE is +0.08%, compared to POM's ROE of +0.16%. Regarding short-term risk, CORT is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for CORT.Check POM's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
CORT vs PAVS Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, PAVS has a market cap of 5.3M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while PAVS trades at $6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas PAVS's P/E ratio is -0.07. In terms of profitability, CORT's ROE is +0.08%, compared to PAVS's ROE of -0.27%. Regarding short-term risk, CORT is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for CORT.Check PAVS's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
CORT vs HKPD Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, HKPD has a market cap of 4.6M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while HKPD trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas HKPD's P/E ratio is -7.01. In terms of profitability, CORT's ROE is +0.08%, compared to HKPD's ROE of -0.14%. Regarding short-term risk, CORT is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for CORT.Check HKPD's competition here
AIxCrypto Holdings, Inc. (NASDAQ: AIXC)
CORT vs AIXC Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, AIXC has a market cap of 4.3M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while AIXC trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas AIXC's P/E ratio is -0.09. In terms of profitability, CORT's ROE is +0.08%, compared to AIXC's ROE of -0.94%. Regarding short-term risk, CORT is less volatile compared to AIXC. This indicates lower risk in terms of short-term price fluctuations for CORT.Check AIXC's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
CORT vs MDVL Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas MDVL's P/E ratio is -0.05. In terms of profitability, CORT's ROE is +0.08%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, CORT is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for CORT.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
CORT vs ATNFW Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas ATNFW's P/E ratio is N/A. In terms of profitability, CORT's ROE is +0.08%, compared to ATNFW's ROE of -2.41%. Regarding short-term risk, CORT is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for CORT.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
CORT vs BGMSP Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, CORT's ROE is +0.08%, compared to BGMSP's ROE of -0.51%. Regarding short-term risk, CORT is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for CORT.Check BGMSP's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
CORT vs BGMS Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, BGMS has a market cap of 2M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while BGMS trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas BGMS's P/E ratio is -0.26. In terms of profitability, CORT's ROE is +0.08%, compared to BGMS's ROE of -0.51%. Regarding short-term risk, CORT is less volatile compared to BGMS. This indicates lower risk in terms of short-term price fluctuations for CORT.Check BGMS's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
CORT vs AZNH Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas AZNH's P/E ratio is 38.35. In terms of profitability, CORT's ROE is +0.08%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, CORT is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for CORT.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
CORT vs LFLYW Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, CORT's ROE is +0.08%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, CORT is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for CORT.Check LFLYW's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFMW)
CORT vs SBFMW Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, SBFMW has a market cap of 175.2K. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while SBFMW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas SBFMW's P/E ratio is N/A. In terms of profitability, CORT's ROE is +0.08%, compared to SBFMW's ROE of -0.26%. Regarding short-term risk, CORT is less volatile compared to SBFMW. This indicates lower risk in terms of short-term price fluctuations for CORT.Check SBFMW's competition here
POZEN Inc. (NASDAQ: POZN)
CORT vs POZN Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, POZN has a market cap of 0. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas POZN's P/E ratio is N/A. In terms of profitability, CORT's ROE is +0.08%, compared to POZN's ROE of +0.61%. Regarding short-term risk, CORT is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for CORT.Check POZN's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
CORT vs CPD Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, CPD has a market cap of 0. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas CPD's P/E ratio is N/A. In terms of profitability, CORT's ROE is +0.08%, compared to CPD's ROE of N/A. Regarding short-term risk, CORT is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for CORT.Check CPD's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
CORT vs ESRX Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, ESRX has a market cap of 0. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas ESRX's P/E ratio is 10.69. In terms of profitability, CORT's ROE is +0.08%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, CORT is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for CORT.Check ESRX's competition here
Shire plc (NASDAQ: SHPG)
CORT vs SHPG Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, SHPG has a market cap of 0. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas SHPG's P/E ratio is 11.35. In terms of profitability, CORT's ROE is +0.08%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, CORT is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for CORT.Check SHPG's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
CORT vs OREX Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, OREX has a market cap of 0. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas OREX's P/E ratio is -0.14. In terms of profitability, CORT's ROE is +0.08%, compared to OREX's ROE of -0.54%. Regarding short-term risk, CORT is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for CORT.Check OREX's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
CORT vs IPXL Comparison August 2026
Corcept Therapeutics Incorporated (NASDAQ: CORT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CORT stands at 12B. In comparison, IPXL has a market cap of 0. Regarding current trading prices, CORT is priced at $110.77 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CORT currently has a P/E ratio of 316.49, whereas IPXL's P/E ratio is -10.11. In terms of profitability, CORT's ROE is +0.08%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, CORT is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for CORT.Check IPXL's competition here